Preclinical efficacy of the synergistic Ruxolitinib–Homoharringtonine combination in TP53-mutated myeloproliferative neoplasms progressing to sAML

Venclexta (venetoclax) - Roche, AbbVie

Synribo (omacetaxine mepesuccinate) - Teva

Jakafi (ruxolitinib) - Incyte

Rumeng Li; Qingmei Han; Tian Zeng; Jiansong Huang; Jian Huang

Dec 5, 2025